Your browser doesn't support javascript.
loading
Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT.
Ye, Yishan; Labopin, Myriam; Chen, Jia; Wu, Depei; Gedde-Dahl, Tobias; Blaise, Didier; Socie, Gérard; Forcade, Edouard; Salmenniemi, Urpu; Maury, Sébastien; Versluis, Jurjen; Bazarbachi, Ali; Nagler, Arnon; Brissot, Eolia; Li, Lin; Luo, Yi; Shi, Jimin; Ciceri, Fabio; Huang, He; Mohty, Mohamad; Gorin, Norbert Claude.
Afiliação
  • Ye Y; The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Labopin M; EBMT Paris Office, Hôpital Saint Antoine 184, rue du faubourg Saint Antoine, 75571, Paris, cedex 12, France.
  • Chen J; First Affiliated Hospital of Soochow University, Suzhou, China.
  • Wu D; First Affiliated Hospital of Soochow University, Suzhou, China.
  • Gedde-Dahl T; Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Blaise D; Program of Transplant and cellular immunotherapy, Department of Hematology, Institut Paoli Calmettes, Management Sport Cancer (MSC) Lab, Aix Marseille University (AMU), Marseille, France.
  • Socie G; Saint-Louis Hospital, BMT Unit, Paris, France.
  • Forcade E; CHU Bordeaux, Hopital Haut-Leveque, Pessac, France.
  • Salmenniemi U; HUCH Comprehensive Cancer Center, Helsinki, Finland.
  • Maury S; Hôpital Henri Mondor, Creteil, France.
  • Versluis J; Erasmus MC Cancer Institute, Rotterdam, Netherlands.
  • Bazarbachi A; Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • Nagler A; Department of Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
  • Brissot E; EBMT Paris Office, Hôpital Saint Antoine 184, rue du faubourg Saint Antoine, 75571, Paris, cedex 12, France.
  • Li L; Department of Hematology and Cell therapy, Hospital Saint-Antoine, Sorbonne University, Paris, France.
  • Luo Y; The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Shi J; The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Ciceri F; The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Huang H; Ospedale San Raffaele s.r.l., Haematology and BMT, Milano, Italy.
  • Mohty M; The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. hehuangyu@126.com.
  • Gorin NC; EBMT Paris Office, Hôpital Saint Antoine 184, rue du faubourg Saint Antoine, 75571, Paris, cedex 12, France. mohamad.mohty@imserm.fr.
Blood Cancer J ; 14(1): 85, 2024 May 27.
Article em En | MEDLINE | ID: mdl-38802349

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rearranjo Gênico / Leucemia Mieloide Aguda / Histona-Lisina N-Metiltransferase / Transplante de Células-Tronco Hematopoéticas / Proteína de Leucina Linfoide-Mieloide Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rearranjo Gênico / Leucemia Mieloide Aguda / Histona-Lisina N-Metiltransferase / Transplante de Células-Tronco Hematopoéticas / Proteína de Leucina Linfoide-Mieloide Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article